Harvard Pilgrim and Illumina sign first-of-its-kind value-based contract
February 20, 2018 10:00 ET
|
Real Endpoints
SAN DIEGO, WELLESLEY, Mass. and WESTPORT, Conn., Feb. 20, 2018 (GLOBE NEWSWIRE) -- Illumina, Inc. and Harvard Pilgrim Health Care announced on February 1 a major new value-based contract (VBC) – one...
CombiMatrix Corporation Stockholders Approve Merger Agreement With Invitae Corporation
November 10, 2017 16:15 ET
|
CombiMatrix Corporation
IRVINE, Calif., Nov. 10, 2017 (GLOBE NEWSWIRE) -- CombiMatrix Corporation (NASDAQ:CBMX) ("CombiMatrix" or the "Company"), a family health molecular diagnostics company specializing in DNA-based...
CombiMatrix Corporation Reports Second Quarter 2017 Financial and Operating Results
August 03, 2017 06:00 ET
|
CombiMatrix Corporation
IRVINE, Calif., Aug. 03, 2017 (GLOBE NEWSWIRE) -- CombiMatrix Corporation (NASDAQ:CBMX), a family health molecular diagnostics company specializing in DNA-based reproductive health and pediatric...
CombiMatrix Appoints Molecular Diagnostics Veteran Dirk van den Boom, Ph.D. to its Board of Directors
March 01, 2017 06:00 ET
|
CombiMatrix Corporation
IRVINE, Calif., March 01, 2017 (GLOBE NEWSWIRE) -- CombiMatrix Corporation (NASDAQ:CBMX), a family health molecular diagnostics company specializing in DNA-based reproductive health and pediatric...
CombiMatrix Corporation Reports 2016 Fourth Quarter and Full Year Financial and Operating Results
February 22, 2017 16:05 ET
|
CombiMatrix Corporation
Achieves record quarterly reproductive health revenues and test volume, across-the-board increases in average revenue per test, expanded gross margin, significantly narrowed operating loss and record...
CombiMatrix Corporation to Release 2016 Fourth Quarter and Full Year Financial Results on February 22, 2017
February 15, 2017 06:00 ET
|
CombiMatrix Corporation
IRVINE, Calif., Feb. 15, 2017 (GLOBE NEWSWIRE) -- CombiMatrix Corporation (NASDAQ:CBMX), a family health molecular diagnostics company specializing in DNA-based reproductive health and pediatric...
CombiMatrix to Present at 2nd Annual Disruptive Growth & Healthcare Conference
February 08, 2017 06:00 ET
|
CombiMatrix Corporation
IRVINE, Calif., Feb. 08, 2017 (GLOBE NEWSWIRE) -- CombiMatrix Corporation (NASDAQ:CBMX), a family health molecular diagnostics company specializing in DNA-based reproductive health and pediatric...
CombiMatrix to Present Large-Scale Study Indicating the Severity of Genomic Abnormalities Decreases from Conception to Childhood at the 2nd Congress on Recurrent Pregnancy Loss
January 20, 2017 06:00 ET
|
CombiMatrix Corporation
IRVINE, Calif., Jan. 20, 2017 (GLOBE NEWSWIRE) -- CombiMatrix Corporation (NASDAQ:CBMX), a family health molecular diagnostics company specializing in DNA-based reproductive health and pediatric...
CombiMatrix Corporation Reports Third Quarter 2016 Financial and Operating Results
November 02, 2016 06:00 ET
|
CombiMatrix Corporation
Rapidly growing revenue, increasing test volume, gross margin expansion, strong cash reimbursement and prudent expense management provide clear path to profitability Conference call begins today...
CombiMatrix Corporation to Release 2016 Third Quarter Financial Results on November 2, 2016
October 26, 2016 06:00 ET
|
CombiMatrix Corporation
IRVINE, Calif., Oct. 26, 2016 (GLOBE NEWSWIRE) -- CombiMatrix Corporation (NASDAQ:CBMX) announces that it will release financial results for the three and nine months ended September 30, 2016 after...